Do not inj. Follow-up on any symptom indicative of intussusception (severe abdominal pain, persistent vomiting, bloody stools, abdominal bloating &/or high fever). Carefully consider potential benefits & risks before administration in infants who have known or suspected immunodeficiency. Caution to individuals w/ immunodeficient close contacts. Contacts of recent vaccinees should observe personal hygiene. Consider potential risk of apnoea & the need for resp monitoring for 48-72 hr when administering primary immunisation series to very premature infants & those w/ history of resp immaturity. Protective immune response may not be elicited in all vaccinees. Does not protect against gastro-enteritis due to other pathogens than rotavirus. Patients w/ rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this vaccine. Not for use in adults. Should not be used in childn >24 wk of age. No data on safety & efficacy in infants w/ GI illnesses or growth retardation.
Sign Out
